<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for 16 hrs. The protein expression of iNOS (<b><i>A</i></b>), COX-2 (<b><i>B</i></b>), PU.1 (<b><i>C</i></b>), and mPGES-1 (<b><i>D</i></b>) was determined by immunostaining followed by confocol fluorescent microscopy. In each sample group, BMDM was stained with the green fluorescent-labeled antibody for the targeted protein and the blue fluorescent-labeled DAPI for nucleus; the overlay image of each targeted protein and nucleus are shown (magnification: ×200, scale bar: 10 µM). LPS stimulation significantly increased cytosolic expression of iNOS, COX-2, mPGES-1 and PU.1 in BMDM, suggesting newly synthesized protein expression in cytosol. PU.1 also showed strong nuclear ...
<p><i>A</i> to <i>B</i>, Peritoneal macrophages were isolated from naïve or LPS-challenged, RT or he...
<p>Liver lysates obtained from the NZB/W F1 mice receiving PBS, NS1, VP1u or VP2 were probed with an...
<p>BMDM was pretreated with mPGES-1-selective inhibitor CAY10526 at 5, 10, or 20 µM for 0.5 hr prior...
<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for various time points from ...
<p>Peritoneal Macrophages from WT and <i>Txnip<sup>−/−</sup></i> mice on the C57BL/6 background were...
<p>(A) LPS infusion increased the influx of MPO-positive cells into jejunal tissue of control and <i...
<p>A) IEC-6 cells were treated with the indicated concentrations of LPS for 24 hours. B) IEC-6 cells...
<p><b>A.</b> GFP-expressing NUGC-4 cells (5 ×10<sup>6</sup> cells/mouse) were injected into the peri...
<p>BMDM were pretreated with COX-2-selective inhibitor NS-398 (20 µM, 0.5 hr) prior to the treatment...
<p>(A) Upper: PES pretreatment (30 min) inhibited iNOS expression in LPS (2 µg/mL)-stimulated cells ...
<p>(A) PLT-BMDMs and control BMDMs (2.5 × 10<sup>6</sup> cells) were stimulated with LPS (50 ng/mL) ...
<p>Cells were pre-treated with PNAPs at different concentrations for 1 h and then stimulated with or...
<p>HIT-T15 cells were transfected with a construct encoding a PDX-1-GFP fusion protein. PDX-1 locali...
<p>(<b>A</b>) iNOS protein is reduced in <i>Noc</i> KO MEFs following LPS treatment. WT and <i>Noc</...
<p>iNOS activity in macrophages was measured in cells cultured in the presence of <b>(A,B)</b> 50μM ...
<p><i>A</i> to <i>B</i>, Peritoneal macrophages were isolated from naïve or LPS-challenged, RT or he...
<p>Liver lysates obtained from the NZB/W F1 mice receiving PBS, NS1, VP1u or VP2 were probed with an...
<p>BMDM was pretreated with mPGES-1-selective inhibitor CAY10526 at 5, 10, or 20 µM for 0.5 hr prior...
<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for various time points from ...
<p>Peritoneal Macrophages from WT and <i>Txnip<sup>−/−</sup></i> mice on the C57BL/6 background were...
<p>(A) LPS infusion increased the influx of MPO-positive cells into jejunal tissue of control and <i...
<p>A) IEC-6 cells were treated with the indicated concentrations of LPS for 24 hours. B) IEC-6 cells...
<p><b>A.</b> GFP-expressing NUGC-4 cells (5 ×10<sup>6</sup> cells/mouse) were injected into the peri...
<p>BMDM were pretreated with COX-2-selective inhibitor NS-398 (20 µM, 0.5 hr) prior to the treatment...
<p>(A) Upper: PES pretreatment (30 min) inhibited iNOS expression in LPS (2 µg/mL)-stimulated cells ...
<p>(A) PLT-BMDMs and control BMDMs (2.5 × 10<sup>6</sup> cells) were stimulated with LPS (50 ng/mL) ...
<p>Cells were pre-treated with PNAPs at different concentrations for 1 h and then stimulated with or...
<p>HIT-T15 cells were transfected with a construct encoding a PDX-1-GFP fusion protein. PDX-1 locali...
<p>(<b>A</b>) iNOS protein is reduced in <i>Noc</i> KO MEFs following LPS treatment. WT and <i>Noc</...
<p>iNOS activity in macrophages was measured in cells cultured in the presence of <b>(A,B)</b> 50μM ...
<p><i>A</i> to <i>B</i>, Peritoneal macrophages were isolated from naïve or LPS-challenged, RT or he...
<p>Liver lysates obtained from the NZB/W F1 mice receiving PBS, NS1, VP1u or VP2 were probed with an...
<p>BMDM was pretreated with mPGES-1-selective inhibitor CAY10526 at 5, 10, or 20 µM for 0.5 hr prior...